[Tryptophan in the treatment of insomnia in hospitalized psychiatric patients].
In 21 psychiatric in-patients, the efficacy of tryptophan at the dose of 250 and 500 mgr, with or without sodium salicylate, has been evaluated with respect to placebo, according to a double-blind randomized design. The results show that none of the treatment conditions induced significant shortening of sleep latency.
D000328:Adult; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D006760:Hospitalization; D006801:Humans; D001523:Mental Disorders / Q000150:complications*; D012890:Sleep / Q000187:drug effects; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy* / Q000209:etiology; D012980:Sodium Salicylate / Q000627:therapeutic use; D014364:Tryptophan / Q000627:therapeutic use*
D014364:Tryptophan; D012980:Sodium Salicylate
Le tryptophane dans le traitement de l'insomnie chez des patients psychiatriques hospitalisés.